 | • レポートコード：B-GIR09D0310 • 出版社/出版日：GlobalInfoResearch / 2019年9月4日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール • 産業分類：医薬品・ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、抗線維化薬の世界市場について調べ、まとめました。種類別セグメントは、経口、注射、局所等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。抗線維化薬の世界市場概観、メーカー動向、メーカー別抗線維化薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・抗線維化薬の市場概観 ・抗線維化薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・抗線維化薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・抗線維化薬の世界市場規模 ・抗線維化薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・抗線維化薬のアメリカ市場規模推移 ・抗線維化薬のカナダ市場規模推移 ・抗線維化薬のメキシコ市場規模推移 ・抗線維化薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・抗線維化薬のドイツ市場規模推移 ・抗線維化薬のイギリス市場規模推移 ・抗線維化薬のロシア市場規模推移 ・抗線維化薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・抗線維化薬の日本市場規模推移 ・抗線維化薬の中国市場規模推移 ・抗線維化薬の韓国市場規模推移 ・抗線維化薬のインド市場規模推移 ・抗線維化薬の東南アジア市場規模推移 ・抗線維化薬の南米市場分析（ブラジル、アルゼンチン等） ・抗線維化薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・抗線維化薬の種類別分析/販売量、売上、市場シェア（経口、注射、局所） ・抗線維化薬の用途別分析/市場規模（病院薬局、小売薬局、オンライン薬局） ・抗線維化薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・抗線維化薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Dermal fibrosis is a fundamental feature of fatty skin sclerosis and is associated with increased levels of the cytokine transforming growth factor-β. This growth factor may derived from activated leukocytes, recruits macrophages and fibroblasts into the tissue and leads to the production of extracellular matrix proteins By dermal fibroblasts. Anti-Fibrotic Drug as treatment of cutaneous fibrosis that stops the action of TGF-β, reducing the amount of fibrosis.
Scope of the Report:
The worldwide market for Antifibrotic Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Antifibrotic Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Pfizer
Novartis
Sanofi
Merck
Roche
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral
Injectable
Topical
Market Segment by Applications, can be divided into
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antifibrotic Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antifibrotic Drugs, with price, sales, revenue and global market share of Antifibrotic Drugs in 2017 and 2018.
Chapter 3, the Antifibrotic Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antifibrotic Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Antifibrotic Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Antifibrotic Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Antifibrotic Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Oral
1.2.2 Injectable
1.2.3 Topical
1.3 Market Analysis by Applications
1.3.1 Hospitals Pharmacies
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Antifibrotic Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Antifibrotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Antifibrotic Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Antifibrotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Sanofi
2.3.1 Business Overview
2.3.2 Antifibrotic Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sanofi Antifibrotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Merck
2.4.1 Business Overview
2.4.2 Antifibrotic Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck Antifibrotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Roche
2.5.1 Business Overview
2.5.2 Antifibrotic Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Roche Antifibrotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Bayer
2.6.1 Business Overview
2.6.2 Antifibrotic Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bayer Antifibrotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Boehringer Ingelheim
2.7.1 Business Overview
2.7.2 Antifibrotic Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Boehringer Ingelheim Antifibrotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Bristol-Myers Squibb
2.8.1 Business Overview
2.8.2 Antifibrotic Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bristol-Myers Squibb Antifibrotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Antifibrotic Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Antifibrotic Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Antifibrotic Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Antifibrotic Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Antifibrotic Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Antifibrotic Drugs Market Analysis by Regions
4.1 Global Antifibrotic Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Antifibrotic Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global Antifibrotic Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America Antifibrotic Drugs Sales and Growth Rate (2014-2019)
4.3 Europe Antifibrotic Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Antifibrotic Drugs Sales and Growth Rate (2014-2019)
4.5 South America Antifibrotic Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Antifibrotic Drugs Sales and Growth Rate (2014-2019)
5 North America Antifibrotic Drugs by Country
5.1 North America Antifibrotic Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Antifibrotic Drugs Sales and Market Share by Country (2014-2019)
5.1.2 North America Antifibrotic Drugs Revenue and Market Share by Country (2014-2019)
5.2 United States Antifibrotic Drugs Sales and Growth Rate (2014-2019)
5.3 Canada Antifibrotic Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico Antifibrotic Drugs Sales and Growth Rate (2014-2019)
6 Europe Antifibrotic Drugs by Country
6.1 Europe Antifibrotic Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Antifibrotic Drugs Sales and Market Share by Country (2014-2019)
6.1.2 Europe Antifibrotic Drugs Revenue and Market Share by Country (2014-2019)
6.2 Germany Antifibrotic Drugs Sales and Growth Rate (2014-2019)
6.3 UK Antifibrotic Drugs Sales and Growth Rate (2014-2019)
6.4 France Antifibrotic Drugs Sales and Growth Rate (2014-2019)
6.5 Russia Antifibrotic Drugs Sales and Growth Rate (2014-2019)
6.6 Italy Antifibrotic Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Antifibrotic Drugs by Country
7.1 Asia-Pacific Antifibrotic Drugs Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Antifibrotic Drugs Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Antifibrotic Drugs Revenue and Market Share by Country (2014-2019)
7.2 China Antifibrotic Drugs Sales and Growth Rate (2014-2019)
7.3 Japan Antifibrotic Drugs Sales and Growth Rate (2014-2019)
7.4 Korea Antifibrotic Drugs Sales and Growth Rate (2014-2019)
7.5 India Antifibrotic Drugs Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Antifibrotic Drugs Sales and Growth Rate (2014-2019)
8 South America Antifibrotic Drugs by Country
8.1 South America Antifibrotic Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Antifibrotic Drugs Sales and Market Share by Country (2014-2019)
8.1.2 South America Antifibrotic Drugs Revenue and Market Share by Country (2014-2019)
8.2 Brazil Antifibrotic Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina Antifibrotic Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia Antifibrotic Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Antifibrotic Drugs by Countries
9.1 Middle East and Africa Antifibrotic Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Antifibrotic Drugs Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Antifibrotic Drugs Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Antifibrotic Drugs Sales and Growth Rate (2014-2019)
9.3 Turkey Antifibrotic Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt Antifibrotic Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria Antifibrotic Drugs Sales and Growth Rate (2014-2019)
9.6 South Africa Antifibrotic Drugs Sales and Growth Rate (2014-2019)
10 Global Antifibrotic Drugs Market Segment by Type
10.1 Global Antifibrotic Drugs Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Antifibrotic Drugs Sales and Market Share by Type (2014-2019)
10.1.2 Global Antifibrotic Drugs Revenue and Market Share by Type (2014-2019)
10.2 Oral Sales Growth and Price
10.2.1 Global Oral Sales Growth (2014-2019)
10.2.2 Global Oral Price (2014-2019)
10.3 Injectable Sales Growth and Price
10.3.1 Global Injectable Sales Growth (2014-2019)
10.3.2 Global Injectable Price (2014-2019)
10.4 Topical Sales Growth and Price
10.4.1 Global Topical Sales Growth (2014-2019)
10.4.2 Global Topical Price (2014-2019)
11 Global Antifibrotic Drugs Market Segment by Application
11.1 Global Antifibrotic Drugs Sales Market Share by Application (2014-2019)
11.2 Hospitals Pharmacies Sales Growth (2014-2019)
11.3 Retail Pharmacies Sales Growth (2014-2019)
11.4 Online Pharmacies Sales Growth (2014-2019)
12 Antifibrotic Drugs Market Forecast (2019-2024)
12.1 Global Antifibrotic Drugs Sales, Revenue and Growth Rate (2019-2024)
12.2 Antifibrotic Drugs Market Forecast by Regions (2019-2024)
12.2.1 North America Antifibrotic Drugs Market Forecast (2019-2024)
12.2.2 Europe Antifibrotic Drugs Market Forecast (2019-2024)
12.2.3 Asia-Pacific Antifibrotic Drugs Market Forecast (2019-2024)
12.2.4 South America Antifibrotic Drugs Market Forecast (2019-2024)
12.2.5 Middle East and Africa Antifibrotic Drugs Market Forecast (2019-2024)
12.3 Antifibrotic Drugs Market Forecast by Type (2019-2024)
12.3.1 Global Antifibrotic Drugs Sales Forecast by Type (2019-2024)
12.3.2 Global Antifibrotic Drugs Market Share Forecast by Type (2019-2024)
12.4 Antifibrotic Drugs Market Forecast by Application (2019-2024)
12.4.1 Global Antifibrotic Drugs Sales Forecast by Application (2019-2024)
12.4.2 Global Antifibrotic Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Antifibrotic Drugs Picture
Table Product Specifications of Antifibrotic Drugs
Figure Global Sales Market Share of Antifibrotic Drugs by Types in 2018
Table Antifibrotic Drugs Types for Major Manufacturers
Figure Oral Picture
Figure Injectable Picture
Figure Topical Picture
Figure Antifibrotic Drugs Sales Market Share by Applications in 2018
Figure Hospitals Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Figure United States Antifibrotic Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Antifibrotic Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Antifibrotic Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Antifibrotic Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure France Antifibrotic Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure UK Antifibrotic Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Antifibrotic Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Antifibrotic Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure China Antifibrotic Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Antifibrotic Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Antifibrotic Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure India Antifibrotic Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Antifibrotic Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Antifibrotic Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Antifibrotic Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Antifibrotic Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Antifibrotic Drugs Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Antifibrotic Drugs Revenue (Value) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Antifibrotic Drugs Type and Applications
Table Pfizer Antifibrotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Antifibrotic Drugs Type and Applications
Table Novartis Antifibrotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Antifibrotic Drugs Type and Applications
Table Sanofi Antifibrotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Antifibrotic Drugs Type and Applications
Table Merck Antifibrotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Antifibrotic Drugs Type and Applications
Table Roche Antifibrotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Antifibrotic Drugs Type and Applications
Table Bayer Antifibrotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Antifibrotic Drugs Type and Applications
Table Boehringer Ingelheim Antifibrotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Antifibrotic Drugs Type and Applications
Table Bristol-Myers Squibb Antifibrotic Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Antifibrotic Drugs Sales by Manufacturer (2017-2018)
Figure Global Antifibrotic Drugs Sales Market Share by Manufacturer in 2017
Figure Global Antifibrotic Drugs Sales Market Share by Manufacturer in 2018
Table Global Antifibrotic Drugs Revenue by Manufacturer (2017-2018)
Figure Global Antifibrotic Drugs Revenue Market Share by Manufacturer in 2017
Figure Global Antifibrotic Drugs Revenue Market Share by Manufacturer in 2018
Figure Top 3 Antifibrotic Drugs Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Antifibrotic Drugs Manufacturer (Revenue) Market Share in 2018
Figure Global Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure Global Antifibrotic Drugs Revenue and Growth Rate (2014-2019)
Table Global Antifibrotic Drugs Sales by Regions (2014-2019)
Table Global Antifibrotic Drugs Sales Market Share by Regions (2014-2019)
Table Global Antifibrotic Drugs Revenue by Regions (2014-2019)
Figure Global Antifibrotic Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Antifibrotic Drugs Revenue Market Share by Regions in 2018
Figure North America Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure Europe Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure South America Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure North America Antifibrotic Drugs Revenue and Growth Rate (2014-2019)
Table North America Antifibrotic Drugs Sales by Countries (2014-2019)
Table North America Antifibrotic Drugs Sales Market Share by Countries (2014-2019)
Figure North America Antifibrotic Drugs Sales Market Share by Countries (2014-2019)
Figure North America Antifibrotic Drugs Sales Market Share by Countries in 2018
Table North America Antifibrotic Drugs Revenue by Countries (2014-2019)
Table North America Antifibrotic Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Antifibrotic Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Antifibrotic Drugs Revenue Market Share by Countries in 2018
Figure United States Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure Canada Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure Mexico Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure Europe Antifibrotic Drugs Revenue and Growth Rate (2014-2019)
Table Europe Antifibrotic Drugs Sales by Countries (2014-2019)
Table Europe Antifibrotic Drugs Sales Market Share by Countries (2014-2019)
Table Europe Antifibrotic Drugs Revenue by Countries (2014-2019)
Figure Europe Antifibrotic Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Antifibrotic Drugs Revenue Market Share by Countries in 2018
Figure Germany Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure UK Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure France Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure Russia Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure Italy Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Antifibrotic Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Antifibrotic Drugs Sales by Countries (2014-2019)
Table Asia-Pacific Antifibrotic Drugs Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Antifibrotic Drugs Sales Market Share by Countries 2018
Table Asia-Pacific Antifibrotic Drugs Revenue by Countries (2014-2019)
Figure Asia-Pacific Antifibrotic Drugs Revenue Market Share by Countries 2018
Figure China Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure Japan Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure Korea Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure India Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure Southeast Asia Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure South America Antifibrotic Drugs Revenue and Growth Rate (2014-2019)
Table South America Antifibrotic Drugs Sales by Countries (2014-2019)
Table South America Antifibrotic Drugs Sales Market Share by Countries (2014-2019)
Figure South America Antifibrotic Drugs Sales Market Share by Countries in 2018
Table South America Antifibrotic Drugs Revenue by Countries (2014-2019)
Table South America Antifibrotic Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Antifibrotic Drugs Revenue Market Share by Countries in 2018
Figure Brazil Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure Argentina Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure Colombia Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Antifibrotic Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Antifibrotic Drugs Sales by Countries (2014-2019)
Table Middle East and Africa Antifibrotic Drugs Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Antifibrotic Drugs Sales Market Share by Countries in 2018
Table Middle East and Africa Antifibrotic Drugs Revenue by Countries (2014-2019)
Table Middle East and Africa Antifibrotic Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Antifibrotic Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Antifibrotic Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure UAE Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure Egypt Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure Nigeria Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Figure South Africa Antifibrotic Drugs Sales and Growth Rate (2014-2019)
Table Global Antifibrotic Drugs Sales by Type (2014-2019)
Table Global Antifibrotic Drugs Sales Share by Type (2014-2019)
Table Global Antifibrotic Drugs Revenue by Type (2014-2019)
Table Global Antifibrotic Drugs Revenue Share by Type (2014-2019)
Figure Global Oral Sales Growth (2014-2019)
Figure Global Oral Price (2014-2019)
Figure Global Injectable Sales Growth (2014-2019)
Figure Global Injectable Price (2014-2019)
Figure Global Topical Sales Growth (2014-2019)
Figure Global Topical Price (2014-2019)
Table Global Antifibrotic Drugs Sales by Application (2014-2019)
Table Global Antifibrotic Drugs Sales Share by Application (2014-2019)
Figure Global Retail Pharmacies Sales Growth (2014-2019)
Figure Global Online Pharmacies Sales Growth (2014-2019)
Figure Global Antifibrotic Drugs Sales, Revenue and Growth Rate (2019-2024)
Table Global Antifibrotic Drugs Sales Forecast by Regions (2019-2024)
Table Global Antifibrotic Drugs Market Share Forecast by Regions (2019-2024)
Figure North America Sales Antifibrotic Drugs Market Forecast (2019-2024)
Figure Europe Sales Antifibrotic Drugs Market Forecast (2019-2024)
Figure Asia-Pacific Sales Antifibrotic Drugs Market Forecast (2019-2024)
Figure South America Sales Antifibrotic Drugs Market Forecast (2019-2024)
Figure Middle East and Africa Sales Antifibrotic Drugs Market Forecast (2019-2024)
Table Global Antifibrotic Drugs Sales Forecast by Type (2019-2024)
Table Global Antifibrotic Drugs Market Share Forecast by Type (2019-2024)
Table Global Antifibrotic Drugs Sales Forecast by Application (2019-2024)
Table Global Antifibrotic Drugs Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界の粘膜類天疱瘡薬市場予測（～2024年） Mucous membrane pemphigoid is an autoimmune blistering disorder that is characterized by subepithelial bullae. Scope of the Report: The worldwide market for Mucous Membrane Pemphigoid Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from…- 世界のポルフィリン症薬市場予測（～2024年） Porphyria is a group of diseases in which substances called porphyrins build up, negatively affecting the skin or nervous system. Scope of the Report: The worldwide market for Porphyrias Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, f…
- 世界の腫瘍ジェネリック注射薬市場予測（～2024年） Generic drugs are essential in oncology because some anticancer drugs are only available as generics. Scope of the Report: The worldwide market for Oncology Generic Injectable Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx mill…
- 世界のめまい薬市場予測（～2024年） Vertigo is a symptom of several different health conditions such as labyrinthitis and meniere's disease. Scope of the Report: The worldwide market for Vertigo Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, …
- 世界のヘルペス後神経痛薬市場予測（～2024年） Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for postherpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antivi…